Overview

A Study to Evaluate the Safety of D-TRANS Fentanyl With Naltrexone in Adult Patients With Chronic Pain and Who Are Opioid Tolerant

Status:
Completed

Trial end date:
2003-07-01

Target enrollment:

Participant gender:

Summary

The primary objective was to evaluate the safety of D-TRANS fentanyl with naltrexone HCl system compared to the Duragesic (fentanyl transdermal system) in opioid tolerant patients.

Phase:

Phase 2

Details

Lead Sponsor:

Alza Corporation, DE, USA

Treatments:

Fentanyl
Naltrexone